A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain
Clinical trial NCT05661734 · COMPLETED
Trial details
- NCT number
- NCT05661734
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2023-12-12
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.